- Home
- PCRX vs MLAB Comparison
PCRX vs MLAB Comparison
Compare PCRX & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- MLAB
- Stock Information
- Founded
- PCRX 2006
- MLAB 1982
- Country
- PCRX United States
- MLAB United States
- Employees
- PCRX N/A
- MLAB N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- MLAB Industrial Machinery/Components
- Sector
- PCRX Health Care
- MLAB Industrials
- Exchange
- PCRX Nasdaq
- MLAB Nasdaq
- Market Cap
- PCRX 1.2B
- MLAB 777.6M
- IPO Year
- PCRX 2011
- MLAB N/A
- Fundamental
- Price
- PCRX $26.59
- MLAB $140.90
- Analyst Decision
- PCRX Buy
- MLAB Hold
- Analyst Count
- PCRX 10
- MLAB 2
- Target Price
- PCRX $29.30
- MLAB $140.00
- AVG Volume (30 Days)
- PCRX 892.8K
- MLAB 30.0K
- Earning Date
- PCRX 02-27-2025
- MLAB 02-04-2025
- Dividend Yield
- PCRX N/A
- MLAB 0.46%
- EPS Growth
- PCRX N/A
- MLAB N/A
- EPS
- PCRX N/A
- MLAB N/A
- Revenue
- PCRX $694,957,000.00
- MLAB $237,747,000.00
- Revenue This Year
- PCRX $5.14
- MLAB $11.39
- Revenue Next Year
- PCRX $2.44
- MLAB $5.62
- P/E Ratio
- PCRX N/A
- MLAB N/A
- Revenue Growth
- PCRX 4.40
- MLAB 11.68
- 52 Week Low
- PCRX $11.16
- MLAB $83.68
- 52 Week High
- PCRX $31.67
- MLAB $152.75
- Technical
- Relative Strength Index (RSI)
- PCRX 77.75
- MLAB 47.08
- Support Level
- PCRX $25.06
- MLAB $135.11
- Resistance Level
- PCRX $27.10
- MLAB $144.84
- Average True Range (ATR)
- PCRX 1.45
- MLAB 5.76
- MACD
- PCRX 0.28
- MLAB -0.99
- Stochastic Oscillator
- PCRX 86.23
- MLAB 23.26
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.